ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment
A key tool for monitoring breast cancer patients under neoadjuvant treatment is the identification of reliable predictive markers. Ki67 has been identified as a prognostic and predictive marker in ER-positive breast cancer. Ninety ER-positive, HER2 negative locally advanced breast cancer patients re...
Saved in:
| Main Authors: | A Ianza, F Giudici, C Pinello, SP Corona, C Strina, O Bernocchi, M Bortul, M Milani, M Sirico, G Allevi, S Aguggini, A Cocconi, C Azzini, M Dester, V Cervoni, A Bottini, M Cappelletti, D Generali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-06-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428320925301 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness Analysis of Ribociclib plus Letrozole versus Palbociclib plus Letrozole in the United Kingdom
by: Gaurav Suri, et al.
Published: (2019-04-01) -
Letrozole and clomiphene versus letrozole alone for ovulation induction in women with PCOS: a systematic review and meta-analysis
by: Karine Eskandar, et al.
Published: (2025-05-01) -
MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
by: M. V. Zavyalova, et al.
Published: (2016-02-01) -
Abemaciclib and Letrozole in Metastatic Male Breast Cancer
by: Leon Schönfeld, et al.
Published: (2024-11-01) -
LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER
by: M. V. Zavjalova, et al.
Published: (2016-02-01)